Paediatrics Flashcards
What are the 7 treatment steps for asthma for kids aged 5-16
Step Notes
1: Newly-diagnosed asthma Short-acting beta agonist (SABA)
2: (Not controlled on previous step
OR
Newly-diagnosed asthma with symptoms >= 3 / week or night-time waking)
SABA + paediatric low-dose inhaled corticosteroid (ICS)
3 SABA + paediatric low-dose ICS + leukotriene receptor antagonist (LTRA)
4 SABA + paediatric low-dose ICS + long-acting beta agonist (LABA)
In contrast to the adult guidance, NICE recommend stopping the LTRA at this point if it hasn’t helped
5 SABA + switch ICS/LABA for a maintenance and reliever therapy (MART), that includes a paediatric low-dose ICS
6 SABA + paediatric moderate-dose ICS MART
OR consider changing back to a fixed-dose of a moderate-dose ICS and a separate LABA
7 SABA + one of the following options:
-increase ICS to paediatric high-dose, either as part of a fixed-dose regime or as a MART
-a trial of an additional drug (for example theophylline)
-seeking advice from a healthcare professional with expertise in asthma
Describe the stepwise approach for asthma in children less than 5 years old
1
Newly-diagnosed asthma Short-acting beta agonist (SABA)
2
Not controlled on previous step
OR
Newly-diagnosed asthma with symptoms >= 3 / week or night-time waking SABA + an 8-week trial of paediatric MODERATE-dose inhaled corticosteroid (ICS)
After 8-weeks stop the ICS and monitor the child’s symptoms:
-if symptoms did not resolve during the trial period, review whether an alternative diagnosis is likely
-if symptoms resolved then reoccurred within 4 weeks of stopping ICS treatment, restart the ICS at a paediatric low dose as first-line maintenance therapy
-if symptoms resolved but reoccurred beyond 4 weeks after stopping ICS treatment, repeat the 8‑week trial of a paediatric moderate dose of ICS
3 SABA + paediatric low-dose ICS + leukotriene receptor antagonist (LTRA)
4 Stop the LTRA and refer to an paediatric asthma specialist
How much budesonide is in paediatric low / moderate / high dose ICS inhalers
<= 200 micrograms budesonide or equivalent = paediatric low dose
200 micrograms - 400 micrograms budesonide or equivalent = paediatric moderate dose
> 400 micrograms budesonide or equivalent= paediatric high dose.
Severe asthma attack
-Sp02
-PEF
-HR
-RR
-clinical feature
Severe attack
SpO2 < 92% (unlike in adults, SpO2 < 92% may be consistent with a ‘severe’ attack in children)
PEF 33-50% best or predicted
Too breathless to talk or feed
Heart rate
>125 (>5 years)
>140 (1-5 years)
Respiratory rate
>30 breaths/min (>5 years)
>40 (1-5 years)
Use of accessory neck muscles
What are the features of life-threatening asthma attack in children?
SpO2 <92%
PEF <33% best or predicted
Silent chest
Poor respiratory effort
Agitation
Altered consciousness
Cyanosis
What is the treatment for children with mild-moderate acute asthma exacerbation?
For children with mild to moderate acute asthma:
Bronchodilator therapy
give a beta-2 agonist via a spacer (for a child < 3 years use a close-fitting mask)
give 1 puff every 30-60 seconds up to a maximum of 10 puffs
if symptoms are not controlled repeat beta-2 agonist and refer to hospital
Steroid therapy
should be given to all children with an asthma exacerbation
treatment should be given for 3-5 days
Describe the usual prednisolone dose for children aged:
2-5yrs
>5yrs
Age Dose as per BTS Dose as per cBNF
2 - 5 years 20 mg od 1-2 mg/kg od (max 40mg)
> 5 years 30 - 40 mg od 1-2 mg/kg od (max 40mg)
what are the two different types of preschool wheeze?
Over recent years, led by the European Respiratory Society Task Force, the favoured classification for pre-school wheeze is to divide children into one of two groups;
-episodic viral wheeze: only wheezes when has a viral upper respiratory tract infection (URTI) and is symptom free inbetween episodes
-multiple trigger wheeze: as well as viral URTIs, other factors appear to trigger the wheeze such as exercise, allergens and cigarette smoke
Episodic viral wheeze is not associated with an increased risk of asthma in later life although a proportion of children with multiple trigger wheeze will develop asthma.
What is the management of episodic viral wheeze?
Episodic viral wheeze
-treatment is symptomatic only
-first-line is treatment with short acting beta 2 agonists (e.g. salbutamol) or anticholinergic via a spacer
-next step is intermittent leukotriene receptor antagonist (montelukast), intermittent inhaled corticosteroids, or both
-there is now thought to be little role for oral prednisolone in children who do not require hospital treatment
What is the management of multiple trigger wheeze?
Multiple trigger wheeze
trial of either inhaled corticosteroids or a leukotriene receptor antagonist (montelukast), typically for 4-8 weeks
What is acute epiglottitis in children caused by?
Haemophilus influenzae
Give 5 clinical features of acute epiglottitis in children?
Features
-rapid onset
-high temperature, generally unwell
-stridor
-drooling of saliva
-‘tripod’ position: the patient finds it easier to breathe if they are leaning forward and extending their neck in a seated position
What is the diagnosis of acute epiglottitis in children?
Diagnosis is made by direct visualisation (only by senior/airway trained staff, see below). However, x-rays may be done, particularly if there is concern about a foreign body:
a lateral view in acute epiglottis will show swelling of the epiglottis - the ‘thumb sign’
in contrast, a posterior-anterior view in croup will show subglottic narrowing, commonly called the ‘steeple sign’
What is the management of acute epiglottitis in children?
Management
immediate senior involvement, including those able to provide emergency airway support (e.g. anaesthetics, ENT)
endotracheal intubation may be necessary to protect the airway
if suspected do NOT examine the throat due to the risk of acute airway obstruction
the diagnosis is made by direct visualisation but this should only be done by senior staff who are able to intubate if necessary
oxygen
intravenous antibiotics
What is bronchiolitis?
-who is affected?
-Which maternal abs provide protection against this?
Bronchiolitis is a condition characterised by acute bronchiolar inflammation. Respiratory syncytial virus (RSV) is the pathogen in 75-80% of cases. NICE released guidelines on bronchiolitis in 2015. Please see the link for more details.
Epidemiology
most common cause of a serious lower respiratory tract infection in < 1yr olds (90% are 1-9 months, with a peak incidence of 3-6 months). Maternal IgG provides protection to newborns against RSV
higher incidence in winter
What is the most common cause of RSV?
Give 5 clinical features
Basics
respiratory syncytial virus (RSV) is the pathogen in 75-80% of cases
other causes: mycoplasma, adenoviruses
may be secondary bacterial infection
more serious if bronchopulmonary dysplasia (e.g. Premature), congenital heart disease or cystic fibrosis
Features
-coryzal symptoms (including mild fever) precede:
-dry cough
-increasing breathlessness
-wheezing, fine inspiratory crackles (not always present)
-feeding difficulties associated with increasing dyspnoea are often the reason for hospital admission
What 5 features would warrant 999 call for bronchiolitis?
NICE recommend immediate referral (usually by 999 ambulance) if they have any of the following:
-apnoea (observed or reported)
-child looks seriously unwell to a healthcare professional
-severe respiratory distress, for example grunting, marked chest recession, or a respiratory rate of over 70 breaths/minute
-central cyanosis
-persistent oxygen saturation of less than 92% when breathing air.
Which 3 features would warrant you to consider referral for bronchiolitis?
NICE recommend that clinicians ‘consider’ referring to hospital if any of the following apply:
-a respiratory rate of over 60 breaths/minute
-difficulty with breastfeeding or inadequate oral fluid intake (50-75% of usual volume ‘taking account of risk factors and using clinical judgement’)
-clinical dehydration
What is the investigation and management of bronchiolitis?
Investigation
immunofluorescence of nasopharyngeal secretions may show RSV
Management is largely supportive
humidified oxygen is given via a head box and is typically recommended if the oxygen saturations are persistently < 92%
nasogastric feeding may be needed if children cannot take enough fluid/feed by mouth
suction is sometimes used for excessive upper airway secretions
What is croup? What is the most common cause?
-Who gets croup?
-When is this most common?
Croup is a form of upper respiratory tract infection seen in infants and toddlers. It is characterised by stridor which is caused by a combination of laryngeal oedema and secretions. Parainfluenza viruses account for the majority of cases.
Epidemiology
peak incidence at 6 months - 3 years
more common in autumn
Give 4 clinical features of croup
Features
-stridor
-barking cough (worse at night)
-fever
-coryzal symptoms
Describe mild croup
-cough
-stridor
-chest wall recession
-Child behaviour
Occasional barking cough
No audible stridor at rest
No or mild suprasternal and/or intercostal recession
The child is happy and is prepared to eat, drink, and play
Describe moderate croup
-cough
-stridor
-chest wall recession
-Child behaviour
Frequent barking cough
Easily audible stridor at rest
Suprasternal and sternal wall retraction at rest
No or little distress or agitation
The child can be placated and is interested in its surroundings
Describe severe croup
-cough
-stridor
-chest wall recession
-Child behaviour
Frequent barking cough
Prominent inspiratory (and occasionally, expiratory) stridor at rest
Marked sternal wall retractions
Significant distress and agitation, or lethargy or restlessness (a sign of hypoxaemia)
Tachycardia occurs with more severe obstructive symptoms and hypoxaemia